Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
6,144
datasets available to search
ShareScore release 0.9.0
Dataset results
6,144 results for “cancer treatment”
Study of Cisplatin/Vinorelbine +/- Cetuximab as First-line Treatment of Advanced Non Small Cell Lung Cancer (FLEX)
ClinicalTrials.gov study NCT00148798. IPD Sharing: Not stated. Countries: 28. Publications: 5.
Alisertib (MLN8237) in Participants With Ovarian, Fallopian Tube or Peritoneal Cancer Preceded by Phase 1 Study of MLN8237 Plus Paclitaxel Treatment of Ovary or Breast Cancer
ClinicalTrials.gov study NCT01091428. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Testing Trametinib and Dabrafenib as a Potential Targeted Treatment in Cancers With BRAF Genetic Changes (MATCH-Subprotocol H)
ClinicalTrials.gov study NCT04439292. IPD Sharing: Not stated. Countries: 1. Publications: 1.
CUDC-907 Treatment in People With Metastatic and Locally Advanced Thyroid Cancer
ClinicalTrials.gov study NCT03002623. IPD Sharing: NO. Countries: 1. Publications: 3.
Testing Crizotinib as Potentially Targeted Treatment in Cancers With MET Genetic Changes (MATCH - Subprotocol C1)
ClinicalTrials.gov study NCT06357975. IPD Sharing: YES. Countries: 1. Publications: 0.
Magnesium Treatment on Vitamin D Metabolism in Participants Completed Personalized Prevention of Colorectal Cancer Trial
ClinicalTrials.gov study NCT03265483. IPD Sharing: Not stated. Countries: 1. Publications: 3.
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers
ClinicalTrials.gov study NCT06896474. IPD Sharing: YES. Countries: 1. Publications: 51.
A Study to Evaluate the Safety and Efficacy of CyPep-1 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic Cancers
ClinicalTrials.gov study NCT05383170. IPD Sharing: UNDECIDED. Countries: 5. Publications: 9.
A Study of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer Who Have Received Prior Anti-HER2 And Chemotherapy-based Treatment
ClinicalTrials.gov study NCT01702571. IPD Sharing: Not stated. Countries: 43. Publications: 3.
To Compare Efficacy and Safety of CT-P16 and European Union-Approved Avastin as First-Line Treatment for Metastatic or Recurrent Non-Squamous Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT03676192. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study of Tarceva (Erlotinib) or Placebo in Combination With Platinum-Based Therapy as First Line Treatment in Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00883779. IPD Sharing: Not stated. Countries: 7. Publications: 1.
Real-World Observational Study to Describe Treatment Patterns in Patients With HER2-Positive Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer in East Asia
ClinicalTrials.gov study NCT05606094. IPD Sharing: YES. Countries: 4. Publications: 0.
A Study Of Palbociclib (PD-0332991) + Letrozole VS. Placebo+ Letrozole For 1st Line Treatment Of Asian Postmenopausal Women With ER+/HER2- Advanced Breast Cancer [PALOMA-4]
ClinicalTrials.gov study NCT02297438. IPD Sharing: YES. Countries: 5. Publications: 2.
HylaCare in the Treatment of Acute Skin Changes in Patients Undergoing Radiotherapy for Breast Cancer
ClinicalTrials.gov study NCT02165605. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Participants With HR+/HER2- Metastatic Breast Cancer
ClinicalTrials.gov study NCT03901339. IPD Sharing: YES. Countries: 9. Publications: 8.
Treatment Preference and Patient Centered Prostate Cancer Care
ClinicalTrials.gov study NCT02032550. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Trial of a Comprehensive Breast Cancer Treatment Patient Decision Tool
ClinicalTrials.gov study NCT01840163. IPD Sharing: Not stated. Countries: 1. Publications: 2.
BMN 673 (Talazoparib), an Oral PARP Inhibitor, in People With Deleterious BRCA1/2 Mutation-Associated Ovarian Cancer Who Have Had Prior PARP Inhibitor Treatment
ClinicalTrials.gov study NCT02326844. IPD Sharing: NO. Countries: 1. Publications: 3.
Improving Tobacco Treatment Rates for Cancer Patients Who Smoke
ClinicalTrials.gov study NCT04738643. IPD Sharing: NO. Countries: 1. Publications: 1.
Study to Determine Treatment Effects of Denosumab in Patients With Breast Cancer Receiving Aromatase Inhibitor Therapy
ClinicalTrials.gov study NCT00556374. IPD Sharing: YES. Countries: 2. Publications: 5.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.